Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Micropeptide Biotechnology Co., Ltd. is a leading Chinese biotechnology company specializing in the research, development, and large-scale production of bioactive substances, including recombinant proteins and functional peptides. Headquartered in Foshan, Guangdong, the company operates a state-of-the-art 80,000-square-meter GMP-compliant manufacturing facility and maintains a strategic partnership with the National Engineering Research Center for Genetic Medicine at Jinan University. Its core product portfolio features medical-grade solutions such as recombinant mussel mucin dressings, recombinant collagen sterile dressings, and high-activity lyophilized powders for wound care and medical aesthetics. As a prominent CDMO and OEM/ODM provider, the company serves numerous global brands in the pharmaceutical and cosmetic sectors, leveraging its expertise in enzyme engineering and protein stabilization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Micropeptide Biotechnology.